Jean Jacovella

USPTO Granted Patents = 10 (Patent Applications = 8)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 33(Granted Patents)

Location History:

Sophia Antipolis, FR (2015)
Antibes, FR (2016 - 2022)

Company Filing History:

Nestle Skin Health Sa

patents

Years Active: 2015-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11234959 - Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema (2022-02-01),

2. 10874682 - Compositions and the use thereof for treating or preventing rosacea (2020-12-29),

3. 10653659 - Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne (2020-05-19),

4. 10463643 - Composition comprising a compound from the family of avermectins and doxycycline for the treatment of rosacea (2019-11-05),

5. 10376492 - Use of a macrocyclic lactone for treating a complication from a papilloma virus infection (2019-08-13),

6. 10206939 - Treatment of papulopustular rosacea with ivermectin (2019-02-19),

7. 9782425 - Treatment of papulopustular rosacea with ivermectin (2017-10-10),

8. 9233118 - Treatment of papulopustular rosacea with ivermectin (2016-01-12),

9. 9233117 - Treatment of inflammatory lesions of rosacea with ivermectin (2016-01-12),

10. 9089587 - Treatment of papulopustular rosacea with ivermectin (2015-07-28),

Title: The Innovative Contributions of Jean Jacovella

Introduction

Jean Jacovella is a notable inventor based in Antibes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for skin conditions. With a total of 10 patents to his name, Jacovella's work has had a meaningful impact on dermatological therapies.

Latest Patents

Among his latest patents, Jacovella has developed compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema. This invention relates to a pharmaceutical composition that includes ivermectin in a pharmaceutically acceptable carrier, aimed at addressing hand eczema effectively. Additionally, he has created compositions for treating or preventing rosacea, which include a non-steroidal anti-inflammatory compound alongside a compound of the avermectin family.

Career Highlights

Throughout his career, Jacovella has worked with prominent companies in the pharmaceutical industry, including Galderma S.A. and Galderma Holding SA. His expertise in dermatological treatments has positioned him as a key figure in the development of innovative solutions for skin ailments.

Collaborations

Jacovella has collaborated with esteemed colleagues such as Jean-Paul Chappuis and Michael Graeber. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Jean Jacovella's contributions to the field of pharmaceuticals, particularly in dermatology, highlight his innovative spirit and dedication to improving patient care. His patents and collaborations reflect a commitment to advancing medical treatments for skin conditions.

This text is generated by artificial intelligence and may not be accurate.